vs
科迪华(CTVA)与UGI CORP(UGI)财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是UGI CORP的1.9倍($3.9B vs $2.1B),UGI CORP净利率更高(14.4% vs -14.1%,领先28.5%),UGI CORP同比增速更快(3.9% vs -1.7%),科迪华自由现金流更多($4.2B vs $-155.0M),过去两年科迪华的营收复合增速更高(-6.7% vs -7.5%)
科迪华是一家美国农业科技企业,主营种子与作物保护产品,涵盖除草剂、杀虫剂、杀菌剂及生物制剂,业务覆盖全球110个国家,总部位于印第安纳州印第安纳波利斯,旗下大部分种子产品以先锋良种国际品牌销售。
UGI公司是总部位于美国宾夕法尼亚州普鲁士王市的能源企业,主营天然气与电力配送业务,布局覆盖范围广泛,在美国本土及欧洲地区均拥有成熟运营网络,为当地用户提供稳定可靠的能源配送服务。
CTVA vs UGI — 直观对比
营收规模更大
CTVA
是对方的1.9倍
$2.1B
营收增速更快
UGI
高出5.6%
-1.7%
净利率更高
UGI
高出28.5%
-14.1%
自由现金流更多
CTVA
多$4.3B
$-155.0M
两年增速更快
CTVA
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $3.9B | $2.1B |
| 净利润 | $-552.0M | $297.0M |
| 毛利率 | 42.4% | — |
| 营业利润率 | -13.6% | 22.0% |
| 净利率 | -14.1% | 14.4% |
| 营收同比 | -1.7% | 3.9% |
| 净利润同比 | -1246.3% | -20.8% |
| 每股收益(稀释后) | $-0.80 | $1.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTVA
UGI
| Q4 25 | $3.9B | $2.1B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $6.5B | $1.4B | ||
| Q1 25 | $4.4B | $2.6B | ||
| Q4 24 | $4.0B | $2.0B | ||
| Q3 24 | $2.3B | $1.2B | ||
| Q2 24 | $6.1B | $1.4B | ||
| Q1 24 | $4.5B | $2.4B |
净利润
CTVA
UGI
| Q4 25 | $-552.0M | $297.0M | ||
| Q3 25 | $-320.0M | $-13.0M | ||
| Q2 25 | $1.3B | $-163.0M | ||
| Q1 25 | $652.0M | $479.0M | ||
| Q4 24 | $-41.0M | $375.0M | ||
| Q3 24 | $-524.0M | $-273.0M | ||
| Q2 24 | $1.1B | $-48.0M | ||
| Q1 24 | $419.0M | $496.0M |
毛利率
CTVA
UGI
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 54.6% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 52.3% | — | ||
| Q1 24 | 43.2% | — |
营业利润率
CTVA
UGI
| Q4 25 | -13.6% | 22.0% | ||
| Q3 25 | -14.1% | 1.1% | ||
| Q2 25 | 27.9% | -6.8% | ||
| Q1 25 | 17.7% | 26.6% | ||
| Q4 24 | 2.2% | 24.5% | ||
| Q3 24 | -27.2% | -20.4% | ||
| Q2 24 | 21.9% | 5.0% | ||
| Q1 24 | 10.7% | 29.7% |
净利率
CTVA
UGI
| Q4 25 | -14.1% | 14.4% | ||
| Q3 25 | -12.2% | -1.1% | ||
| Q2 25 | 20.4% | -12.0% | ||
| Q1 25 | 14.8% | 18.2% | ||
| Q4 24 | -1.0% | 18.9% | ||
| Q3 24 | -22.5% | -22.6% | ||
| Q2 24 | 17.2% | -3.6% | ||
| Q1 24 | 9.3% | 20.6% |
每股收益(稀释后)
CTVA
UGI
| Q4 25 | $-0.80 | $1.34 | ||
| Q3 25 | $-0.47 | $-0.08 | ||
| Q2 25 | $1.92 | $-0.76 | ||
| Q1 25 | $0.95 | $2.19 | ||
| Q4 24 | $-0.05 | $1.74 | ||
| Q3 24 | $-0.76 | $-1.26 | ||
| Q2 24 | $1.51 | $-0.23 | ||
| Q1 24 | $0.60 | $2.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $251.0M |
| 总债务越低越好 | $1.7B | $6.0B |
| 股东权益账面价值 | $24.1B | $5.0B |
| 总资产 | $42.8B | $15.8B |
| 负债/权益比越低杠杆越低 | 0.07× | 1.19× |
8季度趋势,按日历期对齐
现金及短期投资
CTVA
UGI
| Q4 25 | $4.5B | $251.0M | ||
| Q3 25 | $2.6B | $335.0M | ||
| Q2 25 | $2.1B | $350.0M | ||
| Q1 25 | $2.0B | $426.0M | ||
| Q4 24 | $3.2B | $240.0M | ||
| Q3 24 | $2.5B | $213.0M | ||
| Q2 24 | $2.0B | $183.0M | ||
| Q1 24 | $1.7B | $263.0M |
总债务
CTVA
UGI
| Q4 25 | $1.7B | $6.0B | ||
| Q3 25 | $1.7B | $6.5B | ||
| Q2 25 | $1.7B | $5.7B | ||
| Q1 25 | $1.8B | $6.6B | ||
| Q4 24 | $2.0B | $6.6B | ||
| Q3 24 | $2.0B | $6.4B | ||
| Q2 24 | $2.5B | $6.3B | ||
| Q1 24 | $2.5B | $6.7B |
股东权益
CTVA
UGI
| Q4 25 | $24.1B | $5.0B | ||
| Q3 25 | $25.2B | $4.8B | ||
| Q2 25 | $25.9B | $4.9B | ||
| Q1 25 | $24.3B | $5.0B | ||
| Q4 24 | $23.8B | $4.6B | ||
| Q3 24 | $24.7B | $4.3B | ||
| Q2 24 | $25.2B | $4.7B | ||
| Q1 24 | $24.8B | $4.8B |
总资产
CTVA
UGI
| Q4 25 | $42.8B | $15.8B | ||
| Q3 25 | $42.2B | $15.5B | ||
| Q2 25 | $41.8B | $15.4B | ||
| Q1 25 | $42.1B | $15.7B | ||
| Q4 24 | $40.8B | $15.4B | ||
| Q3 24 | $41.9B | $15.1B | ||
| Q2 24 | $41.5B | $15.1B | ||
| Q1 24 | $43.6B | $15.6B |
负债/权益比
CTVA
UGI
| Q4 25 | 0.07× | 1.19× | ||
| Q3 25 | 0.07× | 1.37× | ||
| Q2 25 | 0.07× | 1.17× | ||
| Q1 25 | 0.07× | 1.32× | ||
| Q4 24 | 0.08× | 1.44× | ||
| Q3 24 | 0.08× | 1.48× | ||
| Q2 24 | 0.10× | 1.34× | ||
| Q1 24 | 0.10× | 1.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.4B | $66.0M |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $-155.0M |
| 自由现金流率自由现金流/营收 | 106.2% | -7.5% |
| 资本支出强度资本支出/营收 | 5.7% | 10.7% |
| 现金转化率经营现金流/净利润 | — | 0.22× |
| 过去12个月自由现金流最近4个季度 | $2.8B | $282.0M |
8季度趋势,按日历期对齐
经营现金流
CTVA
UGI
| Q4 25 | $4.4B | $66.0M | ||
| Q3 25 | $193.0M | $90.0M | ||
| Q2 25 | $947.0M | $289.0M | ||
| Q1 25 | $-2.1B | $684.0M | ||
| Q4 24 | $4.2B | $164.0M | ||
| Q3 24 | $130.0M | $151.0M | ||
| Q2 24 | $451.0M | $390.0M | ||
| Q1 24 | $-2.6B | $522.0M |
自由现金流
CTVA
UGI
| Q4 25 | $4.2B | $-155.0M | ||
| Q3 25 | $36.0M | $-168.0M | ||
| Q2 25 | $829.0M | $67.0M | ||
| Q1 25 | $-2.2B | $538.0M | ||
| Q4 24 | $4.0B | $-47.0M | ||
| Q3 24 | $-24.0M | $-115.0M | ||
| Q2 24 | $337.0M | $185.0M | ||
| Q1 24 | $-2.8B | $353.0M |
自由现金流率
CTVA
UGI
| Q4 25 | 106.2% | -7.5% | ||
| Q3 25 | 1.4% | -14.4% | ||
| Q2 25 | 12.8% | 4.9% | ||
| Q1 25 | -49.9% | 20.4% | ||
| Q4 24 | 100.4% | -2.4% | ||
| Q3 24 | -1.0% | -9.5% | ||
| Q2 24 | 5.5% | 13.7% | ||
| Q1 24 | -61.4% | 14.6% |
资本支出强度
CTVA
UGI
| Q4 25 | 5.7% | 10.7% | ||
| Q3 25 | 6.0% | 22.1% | ||
| Q2 25 | 1.8% | 16.3% | ||
| Q1 25 | 2.1% | 5.5% | ||
| Q4 24 | 4.6% | 10.6% | ||
| Q3 24 | 6.6% | 22.0% | ||
| Q2 24 | 1.9% | 15.2% | ||
| Q1 24 | 3.3% | 7.0% |
现金转化率
CTVA
UGI
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | -3.23× | 1.43× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.43× | — | ||
| Q1 24 | -6.23× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
UGI
暂无分部数据